Skip to Content
 
Center for International Blood and Marrow Transplant Research

IB19-04

Main Content

Impact of donor human leukocyte antigen on transplant outcomes in NPM1 mutated acute myeloid leukemia.

Study #: IB19-04

Study Status: Published

Presentation(s)

2021, TCT Meetings (Oral)

HLA class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated acute myeloid leukemia.

Citation

Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E, Chen YB, Bhatt VR, Beitinjaneh A, Nishihori T, Sharma A, Brown VI, Kamoun M, Diaz MA, Abid MB, Askar M, Kanakry CG, Gragert L, Bolon YT, Marsh SGE, Gadalla SM, Paczesny S, Spellman S, Lee SJ.

Transplantation and Cellular Therapy. 2023, Jul 01: 29(7): 29(7):452.e1-452.e11. doi: 10.1016/j.jtct.2023.03.027. Epub 2023, Mar 29. PMCID:PMC10330307.

PubMed

PMID: 36997024

Abstract